A first for CHOC, a team led by Dr. Terence Sanger and Dr. Joffre Olaya treats a teen’s movement disorder through deep brain stimulation.
An innovative internship approach during COVID-19
At the onset of the COVID-19 crisis, CHOC’s Medical Innovation and Intelligence Institute summer internship prorgram made a quick virtual pivot.
CHOC Launches Telehealth Program to Improve Cardiac Outcomes
An innovative telehealth program helps improve the short- and long-term outcomes of high-risk patients with complex congenital heart defects.
Study determines that Pain Buddy app may aid in reduction of pain severity
A new app may help reduce pain severity in children during cancer treatment, a recently published pilot study finds.
Clinical trials continue the advancement of pediatric oncology treatment
CHOC currently offers more than 140 clinical trials in varying phases, including multiple pharmaceutical industry-sponsored clinical trials.
Investigational Drug Study Leads to FDA Approval for Fenfluramine in Treatment for Dravet Syndrome
Dr. Mary Zupanc was a key investigator in a study that led to FDA approval for a medication to treat children with Dravet syndrome.
